To read more on this topic click here.
Parkinson’s gene therapy could improve motor symptoms
Author: Simge Eva DoganPublished: 14 November 2018
Prep: Cook: Serves:
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.
The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.
The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.
For more information on Parkinson’s and gene therapy please visit the EPDA website.
Share this story
£16,000 a year: the hidden price of Parkinson’s
Research reveals the monetary cost of Parkinson’s for UK familiesREAD MORE
The future of Parkinson’s and medicinal plants
The Parkinson’s Foundation hosts leading expertsREAD MORE
“Since being diagnosed with Parkinson’s, my world has expanded”
The latest in our monthly series profiling WPC2019 bloggersREAD MORE